Genter Capital International Dividend ETF (GENW) Price & Chart

Vodafone ( ($VOD) ) has shared an update. Vodafone Group is a telecommunications company providing mobile and fixed-line connectivity, digital and cybersecurity solutions, and financial services through its Vodafone Business

Here’s a look at today’s key earnings reports from major publicly traded companies. Quantum computing and AI infrastructure will be in focus as several companies report results after large contract

Allianz SE Unsponsored ADR (ALIZY) is scheduled to report 3rd quarter earnings on 11/12/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect Allianz SE Unsponsored ADR to

Barclays ( ($BCS) ) has issued an announcement. A November 2, 2026 pricing agreement said Barclays PLC proposed to issue £750,000,000 of 8.625% fixed rate resetting perpetual subordinated contingent convertible

U.S. stocks ended a turbulent week in the red as a sharp technology sell-off, the midterm election results, and growing concerns over AI spending rattled Wall Street. The S&P 500

RBC Capital lowered the firm’s price target on BBVA (BBVA) to EUR 23.50 from EUR 24 and keeps a Sector Perform rating on the shares. Published first on TheFly –

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s TREVI-OC-02 study is testing torvutatug samrotecan with bevacizumab as first-line maintenance treatment for advanced ovarian, fallopian

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s Phase 3 MATTERHORN-CN study is testing treatment for Chinese patients with operable gastric and gastroesophageal junction

A post in Ben Harrington’s deal-focused Betaville blog discusses rumors that Rhythm Pharmaceuticals (RYTM) is working with Goldman Sachs (GS) and that there are multiple bidders seeking a deal for